Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
405 Leser
Artikel bewerten:
(1)

North America Frac. Sand Inc. / Voycare: Voycare Fast Tracks Development of Medical Second Opinion Online Portal Confirming Entry into China's $100B Telemedicine Industry

COVINA, CA / ACCESSWIRE / February 12, 2020 / North America Frac Sand, Inc. dba Voycare (OTC PINK:NAFS) ("NAFS" or "Voycare"), a California-based medical tourism service provider is announcing today the development of its Chinese language medical second opinion online portal in a move to enter China's rapidly growing telemedicine industry with a projected market size of 700 billion RMB or approximately $US100 billion by the end of 2020. The number of active users receiving telemedicine services in the country is projected to reach 59 million users by end of year, an increase of 31% from the previous year, according to a recent report on Phoenix News Media.

The secure online portal will allow users throughout China and other Mandarin speaking countries to upload medical records, lab reports and radiology reports to be translated into English and sent to doctors in the U.S., for a secondary medical evaluation. Originally slated for a launch later in the year, the online portal will now be accelerated to better facilitate users who continue to seek overseas medical treatment or second opinions, even in times of travel restrictions as seen with the ongoing Coronavirus outbreak, which has temporarily affected outbound travel from China.

"Telemedicine is just another way for us to continue bringing value to our clients when travel becomes difficult or gets in the way of gaining access to overseas medical evaluations," said Voycare CEO, Hong Chen. "Currently many cannot fly from China due to the outbreak, but they can certainly get online to get a second opinion of their medical diagnosis. The same applies to those with limited finances or those experiencing visa problems unable to travel abroad. This is the marvel of telemedicine, there are no borders."

As part of the acceleration process to begin work on the portal, Voycare plans to make some key hires in the coming days, to help with the development and launch of the portal, currently projected for a soft launch by end of March.

For more information about Voycare, please visit, www.voycare.com or follow us on Twitter @nafsvoycare.

About Voycare

North America Frac Sand, Inc. (OTC: NAFS) dba Voycare (www.voycare.com) is a California based medical tourism service provider helping overseas patients gain access to quality health care primarily in the fields of oncology, in vitro fertilization, cosmetic surgery and wellness. Voycare's executive team has over 20 years of cross border tourism experience, specifically servicing Chinese outbound travelers to North and South America.

Safe Harbor Statement

This news release contains certain forward-looking information. All information, other than information regarding historic fact that addresses activities, events or developments that the Company believes, expects or anticipates will or may occur in the future is forward-looking information. The forward-looking information contained in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. The forward-looking information contained in this news release is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from current expectations. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable law, the Company disclaims any obligation to update or modify such forward-looking information, either because of new information, future events or for any other reason. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.

China Telemedicine market reference:

http://finance.ifeng.com/c/7tyObs1q2T2

Contact Information
Voycare

+1.626.784.5846
info@voycare.com
www.voycare.com

SOURCE: North America Frac. Sand Inc. / Voycare



View source version on accesswire.com:
https://www.accesswire.com/576157/Voycare-Fast-Tracks-Development-of-Medical-Second-Opinion-Online-Portal-Confirming-Entry-into-Chinas-100B-Telemedicine-Industry

© 2020 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.